Avenue Therapeutics, Inc. (ATXI) stock
ATXIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.43+0.00 (0.00%)
Close on Oct 16, 2026Market cap $1.42MP/E –Yield –
Avenue Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Avenue Therapeutics's enterprise value was -$525.16K on Oct 16, 2026, against -$2.26M a year earlier. Over the last 5 years it ranged from -$4.32M to $23.09M, with a median of -$1.00M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 16, 2026 | -$525.16K | – |
| 2025 | Dec 31, 2025 | -$2.80M | – |
| 2024 | Dec 31, 2024 | -$346.68K | -184.5% |
| 2023 | Dec 29, 2023 | $410.24K | -72.7% |
| 2022 | Dec 30, 2022 | $1.50M | -89.8% |
| 2021 | Dec 31, 2021 | $14.66M | -84.6% |
| 2020 | Dec 31, 2020 | $95.32M | -34.8% |
| 2019 | Dec 31, 2019 | $146.21M | +177.0% |
| 2018 | Dec 31, 2018 | $52.77M | +375.0% |
| 2017 | Dec 29, 2017 | $11.11M | – |
See a number that looks wrong?